On the recordJanuary 28, 2020
I know that some stakeholders have raised concerns about certain provisions in the bill.
Source
congress.govEditor's note · Context
Matsui acknowledges stakeholder concerns regarding her drug labeling bill.
Share & report
More from Robert Matsui
Feb 1, 2023
As a cochair of the Spectrum Caucus, I understand the increasing demand for spectrum across all industries.
Feb 7, 2023
It is important that this committee and the FCC are working hand-in-glove to advance complementary rather than conflicting policies.
Feb 7, 2023
I am glad that we are building on the progress of our first hearing with another bipartisan discussion today.
Mar 22, 2023
I am concerned about the app's tendency to exacerbate existing mental health challenges.
Other voices in this conversation
